Hi Dingo, for net profit, now what we known is that we need US$5.6mil costing annually (below screen shot is extracted from announcement on 31 Aug 2020)
and what we dont know yet is the annual revenue for FY2021, currently we can only rely on personal assumptions, it is subjective to Ralph's coming AGM updated sales pipeline, I think my case should be concervative to consider Abiomed ramp up and additional sensor from Abimed put into production, done forget below pipeline released by company that the sales forecast is 14mil which exclude 2nd sensor from Abiomed and covid sensors etc. If we follow this forecast, our EPS = (14-5.6)*1.38 / 322 and multiply by the 25 PE, I dont want to proceed the calculation anymore.
Lets see what is this revenue figure during AGM presentation, I would be very happy if it can be same as last year which is around 17mil AUD$ revenue and we can have around 9mil net profit which equals to 2.8c earning per share.
